CN102559910B - 一种聋病易感基因slc26a4 ivs7-2a>g荧光检测试剂盒及其应用 - Google Patents
一种聋病易感基因slc26a4 ivs7-2a>g荧光检测试剂盒及其应用 Download PDFInfo
- Publication number
- CN102559910B CN102559910B CN201210033126.XA CN201210033126A CN102559910B CN 102559910 B CN102559910 B CN 102559910B CN 201210033126 A CN201210033126 A CN 201210033126A CN 102559910 B CN102559910 B CN 102559910B
- Authority
- CN
- China
- Prior art keywords
- ivs7
- primer
- deaf
- amplification
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010011878 Deafness Diseases 0.000 title claims abstract description 22
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 19
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 15
- 238000001917 fluorescence detection Methods 0.000 title claims abstract description 10
- 108091006507 SLC26A4 Proteins 0.000 title abstract description 15
- 230000003321 amplification Effects 0.000 claims abstract description 30
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 26
- 102000007325 Amelogenin Human genes 0.000 claims abstract description 16
- 108010007570 Amelogenin Proteins 0.000 claims abstract description 16
- 238000012360 testing method Methods 0.000 claims abstract description 15
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 239000002777 nucleoside Substances 0.000 claims abstract description 8
- 238000005251 capillar electrophoresis Methods 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 5
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 claims description 10
- 239000002131 composite material Substances 0.000 claims description 4
- 238000003752 polymerase chain reaction Methods 0.000 claims description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims 1
- 206010064571 Gene mutation Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 13
- 239000000203 mixture Substances 0.000 abstract description 9
- 238000001514 detection method Methods 0.000 abstract description 8
- -1 LNA nucleoside Chemical class 0.000 abstract description 5
- 239000007850 fluorescent dye Substances 0.000 abstract description 5
- 239000000178 monomer Substances 0.000 abstract description 5
- 238000013016 damping Methods 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 4
- 108090000790 Enzymes Proteins 0.000 abstract description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 3
- 230000035772 mutation Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 238000001215 fluorescent labelling Methods 0.000 abstract description 2
- 229910021642 ultra pure water Inorganic materials 0.000 abstract description 2
- 239000012498 ultrapure water Substances 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
- 238000011895 specific detection Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000003205 genotyping method Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 101150030803 SLC26A4 gene Proteins 0.000 description 6
- 230000002902 bimodal effect Effects 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 210000002905 vestibular aqueduct Anatomy 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical group C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102100035278 Pendrin Human genes 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003582 temporal bone Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 1
- 101100008044 Caenorhabditis elegans cut-1 gene Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011891 Deafness neurosensory Diseases 0.000 description 1
- 206010014016 Ear malformation Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 208000004843 Pendred Syndrome Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000007886 magnetic bead extraction Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210033126.XA CN102559910B (zh) | 2012-02-14 | 2012-02-14 | 一种聋病易感基因slc26a4 ivs7-2a>g荧光检测试剂盒及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210033126.XA CN102559910B (zh) | 2012-02-14 | 2012-02-14 | 一种聋病易感基因slc26a4 ivs7-2a>g荧光检测试剂盒及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102559910A CN102559910A (zh) | 2012-07-11 |
CN102559910B true CN102559910B (zh) | 2016-02-24 |
Family
ID=46406509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210033126.XA Expired - Fee Related CN102559910B (zh) | 2012-02-14 | 2012-02-14 | 一种聋病易感基因slc26a4 ivs7-2a>g荧光检测试剂盒及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102559910B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101684497A (zh) * | 2008-09-23 | 2010-03-31 | 中国人民解放军总医院 | 一种耳聋易感基因筛查试剂盒 |
-
2012
- 2012-02-14 CN CN201210033126.XA patent/CN102559910B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101684497A (zh) * | 2008-09-23 | 2010-03-31 | 中国人民解放军总医院 | 一种耳聋易感基因筛查试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN102559910A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102534031B (zh) | 一种高特异性聋病易感基因检测试剂盒及其应用 | |
CN103352080B (zh) | 一种遗传性耳聋基因检测试剂盒 | |
CN107385064B (zh) | 一种同时扩增人常染色体snp和str位点的荧光标记复合扩增试剂盒及其应用 | |
CN107227361A (zh) | 用于检测cyp2c19基因多态性的引物、探针及检测试剂盒 | |
CN104830852B (zh) | 一种检测hla‑b*15:02等位基因的多重实时荧光pcr方法 | |
CN105274096A (zh) | 桥式序列区掺入错配碱基的桥式荧光探针及其应用和方法 | |
CN105177115A (zh) | 一种用于指导伊立替康类化疗药物个体化治疗的ugt1a1联合基因位点荧光检测试剂盒 | |
CN111118138A (zh) | 一种叶酸代谢能力基因mthfr和mtrr多态性检测试剂盒及方法 | |
CN106939334B (zh) | 一种孕妇血浆中胎儿dna含量的检测方法 | |
CN102586433B (zh) | 一种聋病易感基因12S rRNA 1494C>T荧光检测试剂盒及其应用 | |
CN103451302A (zh) | 聋病易感基因线粒体12SrDNA 1555A>G、1494C>T突变比例检测试剂盒 | |
CN109321651A (zh) | 一种检测人cyp2d6基因多态性的组合物、试剂盒、样品处理方法和应用 | |
CN107338287B (zh) | Taqman-MGB探针检测绵羊BMPR-IB基因A746G突变的试剂盒和方法 | |
CN109182493A (zh) | 人16p11.2微缺失综合征检测的引物和试剂盒及其检测方法 | |
CN102534030B (zh) | 4个聋病易感基因联合检测试剂盒及其应用 | |
CN107904290A (zh) | Pdgfra基因突变检测体系及其试剂盒 | |
CN110878351A (zh) | 用于荧光定量pcr检测mthfr基因多态性的方法 | |
CN110819709A (zh) | 用于荧光定量pcr检测cyp2c9和vkorc1基因多态性的方法 | |
CN116064842A (zh) | 一种用于降解检材推断的生物地理祖先DIPs和性别鉴定的复合扩增盒 | |
CN102559910B (zh) | 一种聋病易感基因slc26a4 ivs7-2a>g荧光检测试剂盒及其应用 | |
CN102660636A (zh) | 一种聋病易感基因12S rRNA 1555A>G荧光检测试剂盒及其应用 | |
CN110628921B (zh) | 一种人DIP-InDel基因座荧光标记试剂盒及检测方法 | |
CN103451301B (zh) | 聋病易感基因slc26a4 2168a>g、ivs7-2a>g突变检测试剂盒 | |
CN107083429B (zh) | 一种用于房颤易感基因检测的snp分型试剂盒及其应用 | |
CN103451300B (zh) | 聋病易感基因GJB2 235delC、299delAT突变检测试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160118 Address after: 201900, room 668, No. 1196, Da Dao, Baoshan District, Shanghai Applicant after: Baishijia (Shanghai) Medical Technology Co., Ltd. Address before: 100101 Beijing city Chaoyang District Datun Road No. 15 Applicant before: Beijing Kelingjinyi Biotechnology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170418 Address after: 201200 Shanghai City King Road Chuansha town Pudong District No. 999 Jobon business park 1014-D Patentee after: Wan Gejiang Address before: Room 668, Baoshan District Road, Shanghai, No. 1196 Patentee before: Baishijia (Shanghai) Medical Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160224 Termination date: 20200214 |
|
CF01 | Termination of patent right due to non-payment of annual fee |